• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Chinese Developed New Drug Exploits the Field of Diabetes PharmaSources/Yi
    November 01, 2021
    Recently, the marketing application of chiglitazar sodium tablets, a new type 1 drug of Chipscreen (the relevant acceptance No. is CXHS1900032), has entered the administrative examination and approval stage, and it is expected that...

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service